IA
ADMA icon

Inspire Advisors’s ADMA Biologics ADMA Stock Holding History

Inspire Advisors’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-23,547
Closed -$429K – 533
2025
Q2 		$429K Buy
23,547
+1,560
+7% +$31.8K 0.04% 317
2025
Q1 		$436K Sell
21,987
-407
-2% -$7.04K 0.05% 292
2024
Q4 		$384K Buy
22,394
+1,532
+7% +$28.8K 0.05% 278
2024
Q3 		$417K Buy
+20,862
New +$324K 0.05% 261

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.82B AUM 73.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Inspire Advisors's ADMA Position: Q3 2025 in Review

Inspire Advisors sold out of ADMA Biologics (ADMA) in Q3 2025, closing a stake of 23,547 shares — an estimated $429K sold.

Inspire Advisors first reported a position in ADMA in Q3 2024 and held it in 4 quarters. The position peaked at $436K in Q1 2025. 365 funds tracked by Wall St. Rank hold ADMA as of Q3 2025.

  • Inspire Advisors reported no remaining ADMA Biologics position as of Q3 2025 after selling out during the quarter.
  • Inspire Advisors sold 23,547 ADMA Biologics shares in Q3 2025, an estimated $429K.
  • Inspire Advisors first reported a position in ADMA Biologics in Q3 2024 and held it in 4 quarters.
  • Inspire Advisors's ADMA Biologics position peaked at $436K in Q1 2025.
  • 365 funds tracked by Wall St. Rank held ADMA Biologics as of Q3 2025.

Based on Inspire Advisors's 13F filing for Q3 2025, filed 29 Oct 2025.